Visiongain Report Analyses Leading Payers within the $173bn Oncology Drugs Market

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 157-page report you will receive 83 tables and 64 figures–all unavailable elsewhere.

The 157-page report provides clear detailed insight into the top 30 oncology drugs manufacturers. Discover the key drivers and challenges affecting the market.

By ordering and reading Visiongain’s brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website:

Report Scope

• Assessment of the leading companies in the global oncology drugs market. The list below shows some of the companies that are discussed in the report:
• Abbott Laboratories
• AbbVie
• Amgen
• Astellas Pharma
• AstraZeneca
• Aurora Biophama
• Boehringer Ingelheim
• Bristol-Myers Squibb (BMS)
• Celgene Corporation
• Eli Lilly
• Fresenius Kabi
• Gilead
• GlaxoSmithKline (GSK)
• Grifols
• Johnson & Johnson
• Jounce Therapeutics
• Other companies

• For each company, the report provides information and discussion on:
• Company overview
• Product portfolio
• Recent development
• Financial information

• Key questions answered by this report:
• How is the Oncology Drugs Manufacturers market evolving?
• What is driving and restraining the Oncology Drugs Manufacturers market?
• What will be the main driver for the overall market?
• Will leading Oncology Drugs Manufacturers broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• Who are the leading players and what are their prospects over the forecast period?

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website:

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

Companies covered in the report include:

Abbott Laboratories, Inc.
Ablynx NV 
Agios Pharmaceuticals, Inc. 
Allergan plc. 
Allogene Therapeutics, Inc. 
ARMO BioSciences, Inc. 
Astellas Pharma Inc. 
AurKa Pharma, Inc. 
Aurora Biopharma, Inc.
Bavarian Nordic 
BioNTech AG. 
Bristol-Myers Squibb
Boehringer Ingelheim
Calithera Biosciences 
Celgene Corporation
Celgene International Sarl
CytomX Therapeutics 
Eisai Co., Ltd. 
Eli Lilly
Flatiron Health
Flexus Biosciences, Inc. 
Fosun Pharma
Foundation Medicine, Inc.
Fresenius Kabi AG 
Genscript Biotech Corporation
Gilead Science
GlaxoSmithKline (GSK)
Harpoon Therapeutics 
Heptares Therapeutics
IBM Watson
IFM Therapeutics
Immatics Biotechnologies
Janssen Diagnostics, LLC. 
Johnson & Johnson
Jounce Therapeutics, Inc.
Juno Therapeutics, Inc. 
Kimberly-Clark Corporation 
Kite Pharma 
Legend Biotech Ireland Limited 
Legend Biotech USA Inc. 
MD Anderson 
Menarini Industrie Farmaceutiche Riunite Srl
Merck & Co.
Miltenyi Biotec 
Moderna Therapeutics 
Mylan N.V.
Nektar Therapeutics 
Noile-Immune Biotech 
Ono Pharmaceutical Company 
Parker Institute 
Regeneron Pharmaceuticals, Inc
Sangamo Therapeutics
SARAH CANNON Research Institute 
Sorrento Therapeutics, Inc.
Sosei Group Corporation
Sun Pharmaceutical Industries Ltd. 
TerSera Therapeutics LLC 
Tessa Therapeutics Pte Ltd.
Valeant Phamaceuticals International, Inc.
ZIOPHARM Oncology, Inc.

List of Organizations Mentioned in the Report
European Commission 
European Medicines Agency 
Food and Drug Administration (FDA)
Health Canada
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) 
Japanese Ministry of Health, Labour and Welfare 
Johns Hopkins 
World Child Cancer
World Health Organization (WHO)

To see a report overview please e-mail Sara Peerun on [email protected]